The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pre Stab Notice - Kazatomprom

13 Nov 2018 07:44

RNS Number : 1611H
Credit Suisse Securities (Eur) Ltd
13 November 2018
 

 

13TH November 2018

 

Not for distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan or any jurisdiction in which such distribution would be unlawful

 

Joint Stock Company "National Atomic Company "Kazatomprom"

 

Pre-stabilisation Period Announcement

 

Credit Suisse Securities (Europe) Limited (contact: Lloyd Adams; +44 (0) 207 888 6341) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with the Commission Delegated Regulation (EU) 2016/1052 under the Market Abuse Regulation (EU/596/2016). Stabilisation transactions aim at supporting the market price of the securities during the stabilisation period. Stabilisation may not necessarily occur and it may cease at any time.

 

The securities:

 

Issuer:

Joint stock company "National Atomic Company "Kazatomprom"

Securities:

Global Depositary Receipts ("GDRs") with no par value and with each GDR representing one ordinary share of the Issuer

ISIN: US63253R2013 (Regulation S) or US63253R1023 (Rule 144A)

Guarantor (if any):

N/A

Description:

Global Depositary Receipts ("GDRs")

Aggregate nominal amount /Offering size:

29,010,971 GDRs (excluding the over-allotment option)

Offer price:

US$ 11.60

Other offer terms:

N/A

Stabilisation:

 

Stabilisation Manager(s):

Credit Suisse Securities (Europe) Limited

(Acting on behalf of Credit Suisse AG)

Stabilisation period expected to start on:

13th November 2018 at 08:00am London time

Stabilisation period expected to end no later than:

13th December 2018 (30 days after the proposed issue date of the securities)

Existence, maximum size and conditions of use of over-allotment facility

The Stabilising Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law.

Joint-stock company "Sovereign Wealth Fund "Samruk-Kazyna" has granted to the Stabilising Manager the over-allotment option, pursuant to which the Stabilising Manager may purchase additional GDRs up to a maximum of 4,351,646 GDRs

Stabilisation trading venue

London Stock Exchange

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAGGGQGGUPRUMW

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.